Market By Product, Test Type, Technology And Geography | Forecast 2019-2027
Triton Market Research estimates the Asia-Pacific newborn screening market to show an upward trend in terms of revenue and expand with a CAGR of 14.38% in the forecasting period of 2019-2027.
The countries that have been studied in the Asia-Pacific newborn screening market are:
• China
• Japan
• India
• South Korea
• ASEAN Countries
• Australia & New Zealand
• Rest of Asia-Pacific
Report scope can be customized per your requirements. Request For Customization
The rise of the newborn screening market in China is backed by government programs supporting newborn screening, owing to the increasing instances of congenital disabilities among newborns in the country. According to the ‘China Disabled Persons’ Federation’, approximately 900,000 babies in China are born with birth defects every year. The increase in birth defects such as critical congenital heart defect (CCHD), sickle cell diseases and hearing loss has led to the increase in demand for newborn screening, as these procedures aid in the determination of treatment of these defects at early stages to prevent deaths, intellectual disability and other disabilities. In addition, China has also abolished its ‘one-child policy’, which is expected to increase the number of births in the country.
India is one of the most populated countries with a high annual birth rate. The growth of the newborn screening market in India is primarily driven by the high annual birth rate and the increasing prevalence of birth defects among newborns in the country. According to the World Bank, the crude birth rate in India was 19 babies per 1000 people. Furthermore, the prevalence of birth defects is also increasing in India. According to the National Health Portal (NHP), the prevalence of birth defects in India is 6-7% each year, that translates to approximately 1.7 million birth defects. The common birth defects include congenital deafness, congenital heart disease and neural tube defects. Newborn screening can be used for early identification of these defects. Early identification may help in treatment, that may prevent deaths and other disabilities in newborns. Thus, the demand for newborn screening is expected to increase in India.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC NEWBORN SCREENING MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS
RISING STEADILY
2.2.2. GROWTH IN DRY BLOOD SPOT TEST
2.2.3. TECHNIQUES USED IN NEWBORN SCREENING TESTS
2.3. EVOLUTION & TRANSITION OF NEWBORN
SCREENING
2.4. PORTER’S FIVE FORCE ANALYSIS
2.4.1. THREAT OF NEW ENTRANTS
2.4.2. THREAT OF SUBSTITUTE
2.4.3. BARGAINING POWER OF SUPPLIERS
2.4.4. BARGAINING POWER OF BUYERS
2.4.5. THREAT OF COMPETITIVE RIVALRY
2.5. KEY IMPACT ANALYSIS
2.5.1. RELIABILITY
2.5.2. COST
2.5.3. AVAILABILITY
2.5.4. TECHNOLOGICAL ADVANCEMENT
2.6. MARKET ATTRACTIVENESS INDEX
2.7. VENDOR SCORECARD
2.8. INDUSTRY COMPONENTS
2.8.1. RAW MATERIAL SUPPLIERS
2.8.2. MANUFACTURERS
2.8.3. DISTRIBUTORS
2.8.4. END-USERS
2.9. REGULATORY FRAMEWORK
2.10. INDUSTRY PLAYER POSITIONING
2.11. KEY MARKET STRATEGIES
2.11.1. PRODUCT LAUNCH
2.12. MARKET DRIVERS
2.12.1. INCREASE IN OCCURRENCES OF NEWBORN DISEASES
2.12.2. GROWING NUMBER OF INFANTS WITH BIRTH DEFECT
2.12.3. BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD
HEALTH
2.12.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL
HEART DISEASE
2.13. MARKET RESTRAINTS
2.13.1. ABSENCE OF PROPER HEALTHCARE INFRASTRUCTURE
FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
2.13.2. SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION
OF NEWBORN CHILD SCREENING
2.14. MARKET OPPORTUNITIES
2.14.1. NEWBORN SCREENING HELPS IN EARLY
IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
2.14.2. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN
SCREENING
2.14.3. INCREASE IN NUMBER OF PREGNANT WOMEN WITH
ADVANCED MATERNAL AGE
2.15. MARKET CHALLENGES
2.15.1. DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE
INDUSTRY
2.15.2. MAINTENANCE OF EQUIPMENT IN HOSPITAL
3. NEWBORN SCREENING MARKET OUTLOOK - BY PRODUCT
3.1. NEWBORN SCREENING INSTRUMENTS
3.2. NEWBORN SCREENING REAGENTS & ASSAY KITS
4. NEWBORN SCREENING MARKET OUTLOOK - BY TEST
TYPE
4.1. HEARING SCREEN TEST
4.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
4.3. DRY BLOOD SPOT TEST
5. NEWBORN SCREENING MARKET OUTLOOK - BY
TECHNOLOGY
5.1. TANDEM MASS SPECTROMETRY
5.2. PULSE OXIMETRY
5.3. ENZYME-BASED ASSAYS
5.4. DNA-BASED ASSAYS
5.5. ELECTROPHORESIS
5.6. OTHERS
6. NEWBORN SCREENING MARKET - REGIONAL OUTLOOK
6.1. CHINA
6.2. JAPAN
6.3. INDIA
6.4. SOUTH KOREA
6.5. ASEAN COUNTRIES
6.6. AUSTRALIA & NEW ZEALAND
6.7. REST OF ASIA-PACIFIC
7. COMPETITIVE LANDSCAPE
7.1. SCIEX
7.2. BIOTEK INSTRUMENTS, INC.
7.3. BIO-RAD LABORATORIES, INC.
7.4. CARDINAL HEALTH, INC.
7.5. GE HEALTHCARE, LIMITED
7.6. AGILENT TECHNOLOGIES, INC.
7.7. MASIMO CORPORATION
7.8. NATUS MEDICAL, INCORPORATED
7.9. MEDTRONIC PLC
7.10. THERMO FISHER SCIENTIFIC, INC.
7.11. NEOGEN LABS PVT. LTD.
7.12. PERKINELMER, INC.
7.13. ZENTECH S.A.
7.14. WATERS CORPORATION
7.15. TRIVITRON HEALTHCARE
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
TABLE 1: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027
(IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF PRODUCT LAUNCHES
TABLE 6: INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATHS/
1000 LIVE BIRTHS)
TABLE 7: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027
(IN $ MILLION)
TABLE 8: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027
(IN $ MILLION)
TABLE 9: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027
(IN $ MILLION)
TABLE 10: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027
(IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: KEY BUYING IMPACT ANALYSIS
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: INDUSTRY PLAYER POSITIONING IN 2018 (IN %)
FIGURE 5: FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) IN 2017
FIGURE 6: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY NEWBORN SCREENING
INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY NEWBORN SCREENING
REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST,
2019-2027 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL
HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT
TEST, 2019-2027 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TANDEM MASS
SPECTROMETRY, 2019-2027 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PULSE OXIMETRY,
2019-2027 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY ENZYME-BASED ASSAY,
2019-2027 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY DNA-BASED ASSAYS,
2019-2027 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY ELECTROPHORESIS,
2019-2027 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027
(IN $ MILLION)
FIGURE 17: ASIA-PACIFIC NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018
& 2027 (IN %)
FIGURE 18: CHINA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 19: JAPAN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 20: INDIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 21: SOUTH KOREA NEWBORN SCREENING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 22: ASEAN COUNTRIES NEWBORN SCREENING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 23: AUSTRALIA & NEW ZEALAND NEWBORN SCREENING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 24: REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, 2019-2027 (IN
$ MILLION)